Matching slides 5,849
Current window 4,411-4,440
Pages 195
Rows per page 30
Slide function: Frame Problemclear collectionreset all

Slide function

4,411-4,440 of 5,849

filter-aware
15
23andMe | Investor Presentation Deck | 57 slides23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations 1 hit
28
The slide uses a split-screen layout contrasting the problem (right) with the proposed solution/thesis (left).23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations 1 hit
05
The slide uses a molecular visualization of an antibody to illustrate the two functional arms of a T-cell engager.AbCellera | Results Presentation Deck | 18 slides · AbCellera
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The diagram illustrates the iterative, inefficient nature of conventional drug discovery (immunization/phage display) leading to suboptimal candidates.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
Uses a comparison framework to contrast data availability between small molecules and biologics.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
06
The slide uses a human silhouette to map clinical manifestations to specific body systems.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Includes two testimonials from Key Opinion Leaders (KOLs) to emphasize the patient burden.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide uses a pie chart to show patient segmentation by B6 responsiveness and a timeline/number line to show age of diagnosis, followed by key metrics on clinical complications.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
15
The slide uses a timeline-based visual to show disease progression.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
25
Includes a Kaplan-Meier survival curve and a comparative table of clinical outcomes.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
06
Aeglea BioTherapeutics | Investor Presentation Deck | 38 slidesAeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem1 hit
07
Includes testimonials from KOLs to emphasize the difficulty of patient compliance.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem1 hit
08
The slide uses a pie chart to segment patients and a timeline/number line to show age of diagnosis, followed by key metrics on clinical complications.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem1 hit
15
The slide uses a timeline-based progression of symptoms to illustrate the severity of the disease.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
26
The slide uses a Kaplan-Meier survival curve and a comparative table to illustrate the severity of the disease.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
07
Uses a nested circle diagram to represent the patient funnel (Total -> Diagnosed -> Treated).Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Problem & ComplicationLoop · Logic Chain1 hit
30
The concentric circles likely represent layers of risk or failure modes.Astra | Investor Presentation Deck | 63 slides · Astra
Pitch deck Investor relations 1 hit
08
Uses a timeline-style vertical flow to represent the 'need' metrics.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
15
The slide uses a split-layout: left side defines the condition and market size, right side highlights the 'unaddressed need' (treatment gap, comorbidity, and lack of innovation).ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
22
The slide uses a dual-column layout: left side defines the disease and market size, right side outlines the clinical 'urgent need' using a vertical process/list flow.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
27
Uses a process-style timeline to list key statistics about the OUD crisis.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Loop · Golden Circle1 hit
03
The slide uses a value-chain style diagram to show the 'spends' and 'receives' flow through various ad-tech layers.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
Uses a series of four callout boxes to present key statistics regarding food demand and environmental impact.Benson Hill | Results Presentation Deck | 23 slides · Benson Hill
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
29
The slide uses direct quotes from resignation and stockholder letters to build a case against the former directors.Cano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
32
This is a classic 'Before/After' or 'Claim/Fact' framing used in proxy contests.Cano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
06
Includes Kaplan-Meier survival curves and a comparative table of clinical outcomes.Chimerix | Investor Presentation Deck | 41 slides · Chimerix
Pitch deck Investor relations Beat · Problem StatementLoop · Cost Of Inaction1 hit
07
The chart uses bubble size to represent employment volume and color to represent education level, with a trend arrow indicating the shift toward knowledge work.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations 1 hit
04
Uses a visual metaphor of a fax machine to emphasize the outdated nature of current healthcare communication.Doximity | IPO Presentation Deck | 18 slides · Doximity
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
12
The slide uses a dark background with high-contrast text and a background image of lead-acid batteries to emphasize the 'toxic' nature of the product.Dragonfly Energy | Investor Presentation Deck | 24 slides · Dragonfly Energy
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
54
The slide uses a three-column layout to present distinct strategic questions, each supported by visual context (gameplay/competitor imagery).Embracer Group | Results Presentation Deck | 74 slides · Embracer Group
Conference presentation Investor relations Beat · Action1 hit